Exclusive GLP-1 Focus We specialize specifically in GLP-1 injury cases
The COR-I trial, involving 1,742 participants over 56 weeks, demonstrated 6.1% average weight loss with Contrave versus 1.3% with placebo (Greenway et al., Obesity, 2010)
In a clinical trial published in the New England Journal of Medicine in 2021, researchers found that semaglutide helped people with obesity lose an average of 15% of their body weight
So, GLP-1 prevents more glucose from going into your bloodstream
They deliver both vitamins to mitigate any gaps from reduced food intake, and fiber, probiotics, and prebiotics that help with potential gastric discomfort and constipation side effects
Lactylation not only alters gene expression levels but also impacts biological functions by modifying the physicochemical properties of proteins